![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United States | Publication | April 2022
Michigan’s Occupational Safety and Health Administration (MIOSHA) has released a video to discuss its Ambassador Program for employers. Under the program, an employer may seek a voluntary consultation with a MIOSHA representative to identify and address specific conditions in the workplace.
Originally formed to assist employers in their efforts to protect workers from COVID-19 risks, the Ambassador Program is expected to expand into other areas so that the primary goal of ensuring employee health and safety can be achieved. MIOSHA emphasizes that the program is not designed to identify hazards for the purpose of issuing citations, but to work collegially with employers to eliminate or mitigate potentially problematic conditions. In particular, via the conduct of its Tier 1 and Tier 2 consultations (explained in the video), MIOSHA wants to assist employers in recognizing hazards they might not know exist in the first instance.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023